0001261380-13-000041.txt : 20130614 0001261380-13-000041.hdr.sgml : 20130614 20130614164844 ACCESSION NUMBER: 0001261380-13-000041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130612 FILED AS OF DATE: 20130614 DATE AS OF CHANGE: 20130614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRIDEX CORP CENTRAL INDEX KEY: 0001006045 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770210467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 BUSINESS ADDRESS: STREET 1: 1212 TERRA BELLA AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509404700 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mackaness James H CENTRAL INDEX KEY: 0001422484 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27598 FILM NUMBER: 13914802 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-06-12 0001006045 IRIDEX CORP IRIX 0001422484 Mackaness James H 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 CFO and COO Common Stock 2013-06-12 4 M 0 300 2.49 A 44930 D Common Stock 2013-06-12 4 S 0 300 5.5525 D 44630 D Common Stock 2013-06-12 4 M 0 100 .90 A 21900 D Common Stock 2013-06-12 4 S 0 100 5.5525 D 21800 D Common Stock 2013-06-13 4 M 0 1000 2.49 A 44630 D Common Stock 2013-06-13 4 S 0 1000 5.20 D 43630 D Stock Option Right to Buy 2.49 2013-06-12 4 M 0 300 0 D 2008-02-02 2015-01-02 Common Stock 300 44630 D Stock Option Right to Buy .90 2013-06-12 4 M 0 100 0 D 2009-01-11 2015-12-11 Common Stock 100 21800 D Stock Option Right to Buy 2.49 2013-06-13 4 M 0 1000 0 D 2008-02-02 2015-01-02 Common Stock 1000 43630 D The sale reported in this Form 4 was pursuant to the Reporting Person's Rule 10b5-1 Selling Plan that was effective March 5, 2013. This option was granted pursuant to IRIDEX Corporation's incentive 1998 Stock Plan and is exempt pursuant to Rule 16b-3. The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month. /s/ Susan Bruce, Attorney-in-Fact for James H. Mackaness 2013-06-14